Press Releases
1
07. 2019
Changes in the Supervisory Board of the LTS AG
On June 28th 2019, the shareholders meeting of the LTS AG has elected the four representatives of the equity owners to the supervisory board of the LTS AG.
19
03. 2019
LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment
LTS Lohmann Therapie-Systeme AG (LTS), a market leader in transdermal therapeutic systems, and LEO Pharma A/S, a global leader in dermatology, today announced that the companies will start the clinical trial of microarray patches for the local intradermal treatment of psoriasis.
20
02. 2019
EsoCap announces kick-off of an industrial development collaboration with LTS
EsoCap AG and LTS Lohmann Therapy-Systeme AG announced the start of cooperation on industrial development of a unique drug delivery technology for diseases of the upper gastrointestinal tract.
4
02. 2019
LTS AG donates a new pediatric anaesthesia trolley to the St. Nikolaus-Stifts Hospital in Andernach.
In January members of the Association, along with Dr. Torsten Baehner, head physician of the Anaesthesia and IC unit at St. Nikolaus-Stift Hospital, displayed the trolley for Ulrich Sielaff, member of the board at LTS.
3
01. 2017
LTS Lohmann Therapie Systeme AG to present at the J.P. Morgan 35th Annual Healthcare Conference 2017
LTS announced today that Dr. Tim G. Schlange, member of the LTS management board and CMO of LTS, will present at the J.P. Morgan 35th Annual Healthcare Conference 2017.
